Skip to content
No PriorsNo Priors

From Restoring Sight to Reimagining the Brain, with Max Hodak

Max Hodak, co-founder and CEO of Science Corporation, joins Sarah Guo to discuss the future of vision, brain-computer interfaces, and the human experience. Max explains how Science’s PRIMA retinal implant could restore functional vision for people who have lost their sight, and why treating the brain as a computational system could unlock new approaches to medicine. They explore the broader potential of neural devices, from restoring lost capabilities to expanding human potential, as well as deeper questions around identity, consciousness, and whether the human experience can persist as our biological hardware changes. Max also shares Science’s long-term vision for reducing the fragility of the human condition by repairing, replacing, and ultimately upgrading parts of ourselves. Finally, he discusses the surprising parallels between AI models and biological brains, and why AI may offer a powerful new lens for understanding intelligence. Chapters: 00:00 – Cold Open Trailer 01:40 – Max Hodak Introduction 02:00 – Science Corporation Overview and Origin 02:53 – A Revolutionary Solve for Blindness 06:32 – Scope of Timeline and Engineer Cost 09:10 – Clinic Trial Process 09:45 - The Response from Clinicians 12:21 – Broader Biotech Landscape 14:59 – Brain’s Relationship to Senses 17:35 – The Study of Consciousness 19:50 – Investments in Brain Computer Interface 22:10 – Fertile Ways to Study Neuroscience 24:46 – Biotech Expansion for Science Corporation 27:50 – What Success Looks Like in Neuroscience and Tech 29:06 - Goals Within Human Preservation vs. Adaptation 30:25 – Conclusion

Max Hodakguest
Aug 20, 202631mWatch on YouTube ↗

At a glance

WHAT IT’S REALLY ABOUT

Science Corporation’s path from retinal implants to brain reengineering

  1. Science Corporation positions itself as a medical device company using brain-interface engineering to produce large, observable clinical effect sizes faster than traditional drug discovery.
  2. The company’s flagship product, the PRIMA retinal prosthesis, restores functional “form vision” by projecting images from smart glasses onto a sub-retinal implant, and has received CE Mark approval for European commercialization.
  3. Clinical results are presented as an existence proof (reading and puzzle-solving), while near-term R&D focuses on expanding field of view and adding grayscale and color capability.
  4. Hodak frames BCI as a broad category and argues Science is focused on sensory input/output and boundary-shifting neurotechnology rather than “brain keyboard” convenience products.
  5. The conversation extends to long-run themes—consciousness, continuity of identity, connectomics, and AI–brain representational alignment—as foundations for eventual substrate independence and human adaptation.

IDEAS WORTH REMEMBERING

5 ideas

Science’s core bet is that treating the brain as a computer makes medicine more engineerable than drugs.

Hodak argues that many clinical wins (cochlear implants, DBS, motor-cortex control) come from directly interfacing with neural computation rather than relying on slow, failure-prone molecular discovery. This frames Science Corporation as a device-first company pursuing large, observable effect sizes and iterative engineering improvement.

PRIMA functions like a “cochlear implant for the eye” and has crossed a key regulatory commercialization threshold.

PRIMA is an implanted sub-retinal chip paired with glasses that project a laser image onto the implant, stimulating surviving retinal circuitry to bypass dead photoreceptors in diseases like AMD. The company recently received CE Mark approval, enabling commercial sales in Europe and shifting the project from “moonshot” to deployable product.

The clinical result is a genuine existence proof, but today’s vision is still low-bandwidth and needs iterative upgrades.

In trials, some patients could perform tasks like reading, Sudoku, and crosswords—presented as evidence of “form vision” rather than vague light flashes. Current limitations include a narrow field of view (“looking through a straw”) and black-and-white output; the roadmap is to add grayscale depth and at least red/green color.

They paired near-term retinal prosthetics with longer-horizon biology (gene therapy, biohybrid interfaces) to balance feasibility and ambition.

Science considered multiple intervention points (retina, LGN/thalamus, V1) and multiple modalities (gene therapy, electrical stimulation, ultrasound). They ultimately acquired Pixium (the then state-of-the-art electrical retinal stim approach) and are also developing an in-house retinal gene therapy aimed at human studies soon.

BCI isn’t one market—Science is prioritizing sensory I/O and identity-relevant interfaces over convenience interfaces.

Hodak frames “BCI” as a broad category (like “pharma”), spanning silent speech, assistive control, sensory restoration, and deeper boundary-shifting augmentation. He distinguishes communication tools (e.g., “brain keyboard”) from technologies that redraw the functional boundary of the self by adding new structural capability.

WORDS WORTH SAVING

5 quotes

The brain very literally, very clearly, plainly is a computer.

Max Hodak

People forget that the moonshot worked. Like, we went, we left, like, boot prints on the moon.

Max Hodak

If I put electrodes in M1, you will probably be using a computer in an hour.

Max Hodak

The only organ that you can't even in principle transplant is the brain. The, uh, like, the heart, the pancreas, the liver, the lungs, as far as I'm concerned, they're really support characters.

Max Hodak

There's a s- like, a fragility that we all live... Like, there's this jeopardy that we all live under as part of the human condition, and I think that if we're successful, what will happen is that sense of jeopardy will fade.

Max Hodak

PRIMA retinal prosthesis mechanismCE Mark approval and commercialization in EuropeClinical trial outcomes and limitations (FOV, grayscale, color)Retina vs LGN vs V1 targeting tradeoffsBiohybrid neural interfaces (living neuron graft concept)BCI market taxonomy: communication vs boundary redrawingConsciousness, identity continuity, connectomics, substrate independence

High quality AI-generated summary created from speaker-labeled transcript.

Get more out of YouTube videos.

High quality summaries for YouTube videos. Accurate transcripts to search & find moments. Powered by ChatGPT & Claude AI.